First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level

Haematologica 2026 Open access

Read full text
Authors: Naveen Pemmaraju, Marco Herling, Kendra L. Sweet, Anthony S. Stein, Sumithira Vasu, Todd Rosenblat, David A. Rizzieri, Cristina Papayannidis, Eunice S. Wang, Marina Konopleva, Michael Zuurman, Alessandra Tosolini
+2 more Muzaffar Qazilbash, Andrew A. Lane
DOI: 10.3324/haematol.2025.300036
Cited by: 2

Fields of Study & Subjects

Cutaneous lymphoproliferative disorders research Immunotherapy and Immune Responses Histiocytic Disorders and Treatments

Publication details

Journal / source
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Volume
111
Issue
7
Pages
2508–2513
Publication date
15 January 2026
Language
EN